Clinical Trials Browser

Multiple Myeloma

Carcinoma, Non-Small-Cell Lung

Mesothelioma, Malignant, Mesothelioma

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Diseases

Carcinoma, Hepatocellular, Hepatoblastoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Lung Neoplasms

Oropharyngeal Neoplasms

Hepatoblastoma

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Urinary Bladder Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Nasopharyngeal Carcinoma

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Uterine Cervical Neoplasms

Nasopharyngeal Neoplasms

Ovarian Neoplasms

ENSAT Stage I Adrenal Cortex Carcinoma

Leukemia, Lymphocytic, Chronic, B-Cell

Squamous Cell Cancer of Head and Neck (SCCHN)

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Multiple Myeloma

Nasopharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Nasopharyngeal Neoplasms

Mesothelioma, Malignant, Mesothelioma

Nasopharyngeal Carcinoma

Esophageal Neoplasms

Recurrence, Testicular Neoplasms, Seminoma

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

Nasopharyngeal Cancinoma (NPC)

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Urinary Bladder Neoplasms

Nasopharyngeal Carcinoma

Biliary Tract Neoplasms

Neoplasms, Germ Cell and Embryonal

Sarcoma, Osteosarcoma

Radiation Injuries, Disease Progression

Clinical Trials

TT4B

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

SAFIR-ABC10

ARIAN

PHITT

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

CompARE

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

LYSARI

SASCIA

GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.

BEATcc

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

OVHIPEC-2

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Auto-LLC 2001

Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

RePaIr-HN

NIRVANA-LUNG

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

SHINE

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

DREAM3R

Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

SWENOTECA-ABC

UPFRONT-NECK

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

SALTORL

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

NAUTICAL

DIAMOND

TAB-2

P3BEP

OS2006

Omitting CTV for Primary Tumor in LS-SCLC